久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Alynlam completes EU, US filings for lumasiran pharmatimes
    April 10, 2020
    Alnylam has completed the submission of marketing applications for lumasiran on both sides of the Atlantic for the ultra-rare inherited disease primary hyperoxaluria type 1 (PH1).

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service